Literature DB >> 11147760

Heart rate variability in patients with Sjögren's syndrome.

B Tumiati1, F Perazzoli, A Negro, M Pantaleoni, G Regolisti.   

Abstract

Heart rate variability (HRV) gives information about sympathetic parasympathetic autonomic balance. Our purpose was to determine whether HRV is abnormal in patients with Sjögren's syndrome. In 16 patients with Sjögren's syndrome and 30 matched controls, a short time analysis of HRV was performed for both the frequency and the time domain. In the time domain, patients tended to display a slower heart rate, greater R-R variability and higher standard deviation of the mean (SDNN) than did healthy subjects, but the differences were not statistically significant. In the frequency domain the spectral measures of HRV showed a slight reduction of LF and an increase of HF; as a result, the ratio between high and low frequencies, representative of sympathovagal modulation, was significantly reduced. Our data suggest an increase in the parasympathetic control of heart rate in patients with Sjögren's syndrome. This predominance in vagal tone could exert a protective and antiarrhythmic role in patients with primary Sjögren's syndrome, and may be relevant with reference to the lower incidence of sudden death in this disorder compared to other major autoimmune diseases.

Entities:  

Mesh:

Year:  2000        PMID: 11147760     DOI: 10.1007/pl00011180

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

1.  Primary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.

Authors:  W-F Ng; A J Stangroom; A Davidson; K Wilton; S Mitchell; J L Newton
Journal:  QJM       Date:  2012-09-13

2.  Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome.

Authors:  Richard Imrich; Ilias Alevizos; Lolita Bebris; David S Goldstein; Courtney S Holmes; Gabor G Illei; Nikolay P Nikolov
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

3.  Spectral analysis of heart rate and blood pressure variability in primary Sjögren's syndrome.

Authors:  P J Barendregt; J H M Tulen; A H van den Meiracker; H M Markusse
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 4.  Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research.

Authors:  Kristen Davies; Emma Dures; Wan-Fai Ng
Journal:  Nat Rev Rheumatol       Date:  2021-10-01       Impact factor: 20.543

Review 5.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

6.  Autonomic dysfunction in primary Sjogren's syndrome: a prospective cohort analysis of 154 Korean patients.

Authors:  Jung Hee Koh; Seung-Ki Kwok; Jennifer Lee; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2016-03-25       Impact factor: 2.884

Review 7.  Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.

Authors:  Kristen Davies; Wan-Fai Ng
Journal:  Front Immunol       Date:  2021-07-26       Impact factor: 7.561

8.  Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.

Authors:  Julia L Newton; James Frith; Danielle Powell; Kate Hackett; Katharine Wilton; Simon Bowman; Elizabeth Price; Colin Pease; Jacqueline Andrews; Paul Emery; John Hunter; Monica Gupta; Saravanan Vadivelu; Ian Giles; David Isenberg; Peter Lanyon; Adrian Jones; Marian Regan; Annie Cooper; Robert Moots; Nurhan Sutcliffe; Michele Bombardieri; Costantino Pitzalis; John McLaren; Steven Young-Min; Bhaskar Dasgupta; Bridget Griffiths; Dennis Lendrem; Sheryl Mitchell; Wan-Fai Ng
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

9.  Mild autonomic dysfunction in primary Sjögren's syndrome: a controlled study.

Authors:  Fin Z J Cai; Sue Lester; Tim Lu; Helen Keen; Karyn Boundy; Susanna M Proudman; Anne Tonkin; Maureen Rischmueller
Journal:  Arthritis Res Ther       Date:  2008-03-07       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.